Despite declining transfusion rates, overuse of O RhD‐negative red blood cells (RBCs) risks the secure supply of this limited resource. A nationwide prospective audit was performed in Finland to understand… Click to show full abstract
Despite declining transfusion rates, overuse of O RhD‐negative red blood cells (RBCs) risks the secure supply of this limited resource. A nationwide prospective audit was performed in Finland to understand the clinical use and inventory management of O RhD‐negative units. Our aim was to identify areas where policy changes could help alleviate the shortage of O RhD‐negative RBCs.
               
Click one of the above tabs to view related content.